Patrick M. Sweeney & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
9,126
+88
+1% +$20.5K 1.33% 17
2026
Q1
$2.21M Buy
9,038
+4
+0% +$932 1.42% 16
2025
Q4
$1.87M Sell
9,034
-116
-1% -$22.9K 1.17% 19
2025
Q3
$1.7M Buy
9,150
+4
+0% +$685 1.1% 20
2025
Q2
$1.43M Buy
9,146
+102
+1% +$15.7K 0.98% 20
2025
Q1
$1.5M Buy
9,044
+1
+0% +$156 1.12% 19
2024
Q4
$1.31M Buy
9,043
+56
+0.6% +$8.68K 0.98% 21
2024
Q3
$1.46M Buy
8,987
+103
+1% +$16.4K 1.07% 19
2024
Q2
$1.29M Buy
8,884
+221
+3% +$32.9K 1.04% 18
2024
Q1
$1.37M Buy
8,663
+101
+1% +$16.1K 1.13% 18
2023
Q4
$1.34M Buy
+8,562
New +$1.31M 1.23% 17

Other funds holding JNJ

Patrick M. Sweeney & Associates's JNJ Position: Q2 2026 in Review

Patrick M. Sweeney & Associates increased its Johnson & Johnson (JNJ) stake by 0.97% in Q2 2026, buying an estimated $20.5K and bringing the position to 9,126 shares worth $2.32M. The position accounts for 1.33% of the portfolio, ranked #17.

Patrick M. Sweeney & Associates first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Patrick M. Sweeney & Associates held 9,126 shares of Johnson & Johnson worth $2.32M as of Q2 2026.
  • Patrick M. Sweeney & Associates bought 88 Johnson & Johnson shares in Q2 2026, an estimated $20.5K.
  • Johnson & Johnson made up 1.33% of Patrick M. Sweeney & Associates's portfolio in Q2 2026, its #17 holding.
  • Patrick M. Sweeney & Associates first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.